University of Pittsburgh Cancer Institute (UPCI)

Protocol Review Committee

Meeting Schedule

University of Pittsburgh Cancer Institute (UPCI) Protocol Review Committees (PRC) meeting dates and deadline for submission for 2013 are as follows:

COMMITTEE A
3:30-5:00pm, 5 East Conference Room
Andrew Laman, MD (Chairman)

COMMITTEE B
2:00-4:00pm, 5 East Conference Room
Leonard Appleman, MD (Chairman)

Deadline Dates For Submission Meeting Dates Deadline Dates For Submission Meeting Dates
January 3, 2013 January 14, 2013 January 17, 2013 January 28, 2013
January 31, 2013 February 11, 2013 February 14, 201 February 25, 201
February 28, 201 March 11, 2013    
March 28, 2013 April 8, 2013 April 11, 2013 April 22, 2013
April 25, 2013 May 6, 2013 May 9, 2013 May 20, 2013
May 30, 2013 June 10, 2013 June 13, 2013 June 24, 2013
July 3, 2013 July 15, 2013 July 18, 2013 July 29, 2013
August 1, 2013 August 12, 2013 August 15, 2013 August 26, 2013
August 28, 2013 September 9, 2013 September 12, 2013 September 23, 2013
September 26, 2013 October 7, 2013 October 10, 2013 October 21, 2013
October 24, 2013 November 4, 2013 November 7, 2013 November 18, 2013
November 21, 2013 December 2, 2013 December 5, 2013 December 16, 2013

Deadlines for submission to the PRC are approximately 10 days before the scheduled meeting date. Please note that any trials lacking the required documentation for review by EOB on the dates listed above may not be placed on the next meeting agenda.

Required documents are the following:

  1. A completed PRC checklist/program director letter
  2. A copy of full protocol
  3. A sponsor or UPCI consent form
  4. Investigator drug brochure
  5. All trials must receive (e-mail) sign-off from the disease center director and all Investigator-initiated trials must be approved by a University of Pittsburgh Biostatistician prior to submission to the PRC.

Documents can be emailed to Brandon Kaukus at kaukusbm@upmc.edu or call 412-623-3376 if you have any questions.

Note: Any studies with Chairman as PI should be sent to the opposite Committee for review.